HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company’s business strategy and commercial and development-stage programs will be given at the UBS Global Life Sciences Conference being held at The Grand Hyatt in New York City. The Company presentation is on Thursday, September 20, 2012, at 7:30 AM ET.
